Formulation and pharmacodynamic evaluation of meloxicam liquisolid compacts

Latin American Journal of Pharmacy

Volumn 29, Issue 8, 2010, Pages 1303-1310

  Emmadi, Srujan ^a   Sanka, Krishna ^a   Potu, Appa R ^a   Jukanti, Raju ^a   Bandari, Suresh ^a   Veerareddy, Prabhakar R ^a  

^a ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Analgesic; Anti inflammatory; Dissolution efficiency; Liquisolid compacts; Meloxicam; Polyethylene glycol 400

Indexed keywords

ACETIC ACID; AEROSIL; CARRAGEENAN; MACROGOL 400; MELOXICAM; MICROCRYSTALLINE CELLULOSE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PAW EDEMA; RAT; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FRIABILITY; TABLET HARDNESS; WRITHING TEST; X RAY DIFFRACTION;

EID: 78751526861     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Meriani, F., N. Coceani, C. Sirotti, D. Voinovich & M. Grassi (2004) J. Pharm Sci. 93: 540-552.
2. Sameer, S., S. Praveen, B. Shraddha & P. Atmaram (2005) AAPS PharmSciTech 6: Article 76.
3. Kaneniwa, N., A. Ikekawa & K. Hashimoto (1973) Chem. Pharm. Bull. 21: 676-681.
4. Yamamoto, K., M. Nakano, A. Takaichi & Y. Nakai (1974) J. Pharm. Biopharm. 2: 487-93
5. Rasenack, N., H. Hartenhauer & B.W. Muller (2003) Int. J. Pharm. 254: 137-45.
6. Rogers, T.L., K.P. Johnston & Williams (2003) Eur. J. Pharm. Biopharm. 55: 161-172.
7. Kayrak, D., U. Akman & O. Hortacsu, (2002) J. Supercritical Fluids 26: 17-31.
8. Sarkari, M., J. Brown, X.X. Chen, S. Swinnea, R.O. Williams & K.P. Johnston (2002) Int. J. Pharm. 243: 17-31.
9. Elamin, A.A., T. Sebhatu & C. Ahlneck (1995) Int. J. Pharm. 199: 25-36.
10. Parrott, E.L. (1990) Encyclopedia of Pharmaceutical Technology, vol. 3, Marcel Decker, 101-21.
11. Chaumcil, J.C. (1998) Meth. Find. Exp. Clin. Pharmacol. 20: 211-5.
12. Kimura, K.F. Hirayama, H. Arima, K. Uekama (2000) Chem. Pharm. Bull. 48: 646-50.
13. Sheu, M.T., C. M. Yeh, & T. D. Sokoloski (1994) Int. J. Pharm. 103: 137-46.
14. Nokhodchi, A. (2005) J. Pharm. Pharmaceut. Sci. 8: 18-25.
15. Sanjeev, G. & J. Ravindra (2009) Research J. Pharm. and Tech. 2: 382-6.
16. Spireas, S.S., S. Sadu & R. Grover (1998) J. Pharm. Sci. 87: 867-72.
17. El-maradny, H., S. Mortada1 & H.H. Kamel Ahmed (2008) Acta Pharm. 58: 455-66.
18. Spireas, S., & M. Bolton (1999). Liquisolid Systems and Methods of Preparing Same, U.S. Patent 5,968,550.
19. Tayel, S.A., I.I. Soliman & D. Louis (2007) Eur. J. Pharm. Biopharm. 69: 342-7.
20. Spireas, S. (2002). Liquisolid Systems and Methods of Preparing Same, U.S.Patent 6,423, 339 B1.
21. Fahmy, R.H. & M.A. Kassem (2008) Eur. J. Pharm. Biopharm. 69: 993-1003.
22. Staniforth, J. (2002) Powder flow, in: Pharmaceutics, the Science of Dosage Form Design (M. Aulton, ed.), 2nd ed., Churchill Livingstone, Longman group, Edinburgh, pp.197-210.
23. Sammour, O.A., M.A. Hammad, N.A. Megrab & A.S. Zidan (2006) AAPS PharmSciTech. 7: Article 55.
24. Valleri, M., P. Mura, F. Maestrelli, M. Cirri & R. Ballerini.(2004) Drug Dev Ind Pharm. 30: 525-34.
25. Varshosaz, J., Tavakoli N. & Kheirolahi F. (2006) AAPS PharmSciTech. 7: Article 24.
26. Vijaya Kumar, SG & DN Mishra (2006) Iranian J. Pharmacol. Therap. 5: 77-79.
27. Baboota S, M Dhaliwal & K Kohli (2005) AAPS PharmSciTech. 5: 83-90.
28. Ansel, HC, LV Allen & NG. Popovich (1999) Pharmaceutical Dosage forms and drug delivery systems 7th ed. Lippincott Williams and Wilkins, Phildilphia.
29. Shangraw, RF. (1989) Compressed tablets by direct compression, 2nd. ed., Pharmaceutical Dosage Forms Tablets, vol. 1, New York: Marcel Dekker Inc., pp. 195-220.
30. Karmarkar, A.B., I.D. Gonjari, H.H. Avinash, N.D. Pandurang & B. Satish (2009) Lat. Am. J. Pharm 28: 219-225.